(Q43426665)

23 November 2017

title

Double lumen port access in patients receiving allogeneic blood stem cell transplantation (English)

1 reference

23 November 2017

8

Ehninger G

1 reference

23 November 2017

9

Bornhäuser M

1 reference

23 November 2017

1

Platzbecker U

1 reference

23 November 2017

Illmer T

2

1 reference

23 November 2017

Schaich M

3

1 reference

23 November 2017

Freiberg-Richter J

4

1 reference

23 November 2017

Helwig A

5

1 reference

23 November 2017

Plettig R

6

1 reference

23 November 2017

Jenke A

7

1 reference

23 November 2017

language of work or name

English

0 references

publication date

1 December 2001

1 reference

Bone Marrow Transplantation

23 November 2017

published in

1 reference

23 November 2017

volume

28

1 reference

23 November 2017

issue

11

1 reference

23 November 2017

page(s)

1067-1072

1 reference

Hickman catheter-induced thoracic vein thrombosis. Frequency and long-term sequelae in patients receiving high-dose chemotherapy and marrow transplantation

23 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703285

A comparison of placement techniques and complications of externalized catheters and implantable port use in children with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703285

A prospective randomized trial comparing the infectious and noninfectious complications of an externalized catheter versus a subcutaneously implanted device in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703285

Complications from long-term indwelling central venous catheters in hematologic patients with special reference to infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703285

Mode of chemotherapy does not affect complications with an implantable venous access device

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703285

Totally implantable venous access ports systems for patients receiving chemotherapy for solid tissue malignancies: A randomized controlled clinical trial examining the safety, efficacy, costs, and impact on quality of life.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703285

Dose-reduced conditioning for allogeneic blood stem cell transplantation: durable engraftment without antithymocyte globulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703285

7 January 2021

Utility and safety of Hickman catheters for venous access after bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703285

7 January 2021

Intracardiac infections due to coagulase-negative Staphylococcus associated with Hickman catheters

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703285

7 January 2021

Totally implantable central venous access ports for high-dose chemotherapy administration and autologous stem cell transplantation: analysis of overall and septic complications in 68 cases using a single type of device

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703285

7 January 2021

Use of the Hickman-Crawford critical care catheter in marrow transplant recipients: a pulmonary artery catheter-adaptable central venous access.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703285

7 January 2021

Implantable vascular access systems: experience in 1500 patients with totally implanted central venous port systems

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703285

7 January 2021

Subcutaneously implanted central venous access devices in cancer patients: a prospective analysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703285

7 January 2021

Evaluation of an implantable venous access system in a general oncology population

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703285

7 January 2021

Infectious morbidity associated with long-term use of venous access devices in patients with cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703285

7 January 2021

Comparison of a Totally Implantable Access Device for Chemotherapy (Port-A-Cath) and Long-term Percutaneous Catheterization (Broviac)*

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703285

7 January 2021

Implanted right atrial catheters for continuous infusion of solutions into dogs

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703285

7 January 2021

Reliability of implantable central venous access devices in patients with cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703285

7 January 2021

Externalized Groshong catheters and Hickman ports for central venous access in gynecologic oncology patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703285

7 January 2021

Treatment of deep vein thrombosis using temporary vena caval filters after allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703285

7 January 2021

Complications of an implantable venous access device (Port-a-Cath) during intermittent continuous infusion of chemotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703285

7 January 2021

Humoral coagulation and early complications after allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703285

7 January 2021

Identifiers

DOI

10.1038/SJ.BMT.1703285

1 reference

Dimensions Publication ID

23 November 2017

1039574948

0 references

1 reference